Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 5 days, and 1 more · Every feed →

All 19Congress 0Executive branch 0Insiders 19
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ELVN · sells only · $250K+ · 19 trades

Trades
19
Buys 0 · Sells 19
People
7
Stocks
1
Disclosed value
$166M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLJ. Scott Garland DirectorELVN Enliven Therapeutics, Inc.$607Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$270Kdisclosed Aug 19 · filed 2 days after the trade
  3. ▼ SELLMika K Derynck DirectorELVN Enliven Therapeutics, Inc.$9.6Mdisclosed Aug 6 · filed 2 days after the trade
  4. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$299Kdisclosed Jul 8 · filed 2 days after the trade
  5. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  6. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  7. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  8. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  9. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  10. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  11. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  12. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  13. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  14. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade
  15. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade
  16. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  17. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  18. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  19. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade